Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed -$69 115
2022
Q4
$69 Buy
4
+2
+100% +$70 ﹤0.01% 449
2022
Q3
$0 Hold
2
﹤0.01% 464
2022
Q2
$0 Hold
2
﹤0.01% 381
2022
Q1
$0 Hold
2
﹤0.01% 356
2021
Q4
$0 Hold
2
﹤0.01% 376
2021
Q3
$0 Hold
2
﹤0.01% 350
2021
Q2
$0 Hold
2
﹤0.01% 346
2021
Q1
$0 Hold
2
﹤0.01% 378
2020
Q4
$0 Buy
+2
New +$56 ﹤0.01% 355

Other funds holding ADNT

Leelyn Smith's ADNT Position: Q1 2023 in Review

Leelyn Smith sold out of Adient (ADNT) in Q1 2023, closing a stake of 4 shares — an estimated $69 sold.

Leelyn Smith first reported a position in ADNT in Q4 2020 and held it in 9 quarters. The position peaked at $69 in Q4 2022. 275 funds tracked by Wall St. Rank hold ADNT as of Q1 2023.

  • Leelyn Smith reported no remaining Adient position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 4 Adient shares in Q1 2023, an estimated $69.
  • Leelyn Smith first reported a position in Adient in Q4 2020 and held it in 9 quarters.
  • Leelyn Smith's Adient position peaked at $69 in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Adient as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.